He was recently the acting director of the Department of Engineering Physics from 2019 to 2020.
He is the director of the Laser Processing and Plasmonics Laboratory (LP2L), which he founded in 1988, whose mission is to develop diagnostic and therapeutic technologies based on plasmonics and the optical properties of colloidal nanoparticles.
in engineering physics from Polytechnique Montréal in 1978 and 1980, respectively, and his doctorate from the Massachusetts Institute of Technology in 1984.
[1] Holder of a Canada Research Chair from 2002 to 2016, Prof. Michel Meunier is recognized for his research in the field of nanotechnology and laser-matter interaction for medical applications.
He is notably one of the developers of optoporation, which consists of carrying out cell gene transfection using an ultra-fast pulsed laser (femtosecond laser) and of plasmonic nanoparticles, typically gold or gold-silver alloy.